KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 17,349 Value ($000) $342 Avg Close — Range —
Q4 2023
Shares 17,349 Value ($000) $304 Avg Close — Range —
Q2 2023
Shares 17,349 Value ($000) $244 Avg Close — Range —
Q1 2023
Shares 17,349 Value ($000) $187 Avg Close — Range —
Q4 2022
Shares 17,349 Value ($000) $260 Avg Close — Range —
Q3 2022
Shares 17,349 Value ($000) $223 Avg Close — Range —
Q2 2022
Shares 17,349 Value ($000) $168 Avg Close — Range —
Q1 2022
Shares 17,349 Value ($000) $172 Avg Close — Range —
Q4 2021
Shares 11,087 Value ($000) $130 Avg Close — Range —
Q3 2021
Shares 11,087 Value ($000) $126 Avg Close — Range —
Q2 2021
Shares 11,087 Value ($000) $154 Avg Close — Range —
Q1 2021
Shares 11,087 Value ($000) $205 Avg Close — Range —
Q4 2020
Shares 12,290 Value ($000) $217 Avg Close — Range —
Q3 2020
Shares 12,290 Value ($000) $188 Avg Close — Range —
Q2 2020
Shares 9,003 Value ($000) $229 Avg Close — Range —
Q1 2020
Shares 7,092 Value ($000) $110 Avg Close — Range —